141 related articles for article (PubMed ID: 35641659)
21. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study.
Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE
Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592
[TBL] [Abstract][Full Text] [Related]
22. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
23. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
Lord D
Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
[TBL] [Abstract][Full Text] [Related]
24. Practical approach to determine sample size for building logistic prediction models using high-throughput data.
Son DS; Lee D; Lee K; Jung SH; Ahn T; Lee E; Sohn I; Chung J; Park W; Huh N; Lee JW
J Biomed Inform; 2015 Feb; 53():355-62. PubMed ID: 25555898
[TBL] [Abstract][Full Text] [Related]
25. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
[TBL] [Abstract][Full Text] [Related]
26. Logistic regression models for patient-level prediction based on massive observational data: Do we need all data?
John LH; Kors JA; Reps JM; Ryan PB; Rijnbeek PR
Int J Med Inform; 2022 Jul; 163():104762. PubMed ID: 35429722
[TBL] [Abstract][Full Text] [Related]
27. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
28. Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models.
Austin PC; Steyerberg EW
Stat Methods Med Res; 2017 Apr; 26(2):796-808. PubMed ID: 25411322
[TBL] [Abstract][Full Text] [Related]
29. Direct Involvement of Cranial Nerve V at Diagnosis in Patients With Diffuse Intrinsic Pontine Glioma: A Potential Magnetic Resonance Predictor of Short-Term Survival.
Colafati GS; Voicu IP; Carducci C; Caulo M; Vinci M; Diomedi-Camassei F; Merli P; Carai A; Miele E; Cacchione A; Tomà P; Locatelli F; Mastronuzzi A
Front Oncol; 2019; 9():204. PubMed ID: 31019890
[No Abstract] [Full Text] [Related]
30. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.
Rechberger JS; Lu VM; Zhang L; Power EA; Daniels DJ
Childs Nerv Syst; 2020 Jan; 36(1):39-46. PubMed ID: 31489454
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
32. Sample size planning for developing classifiers using high-dimensional DNA microarray data.
Dobbin KK; Simon RM
Biostatistics; 2007 Jan; 8(1):101-17. PubMed ID: 16613833
[TBL] [Abstract][Full Text] [Related]
33. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
34. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes.
Riley RD; Snell KI; Ensor J; Burke DL; Harrell FE; Moons KG; Collins GS
Stat Med; 2019 Mar; 38(7):1276-1296. PubMed ID: 30357870
[TBL] [Abstract][Full Text] [Related]
35. Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data.
Perez A; van der Louw E; Nathan J; El-Ayadi M; Golay H; Korff C; Ansari M; Catsman-Berrevoets C; von Bueren AO
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1383. PubMed ID: 33939330
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study.
Thangaratinam S; Allotey J; Marlin N; Mol BW; Von Dadelszen P; Ganzevoort W; Akkermans J; Ahmed A; Daniels J; Deeks J; Ismail K; Barnard AM; Dodds J; Kerry S; Moons C; Riley RD; Khan KS
Health Technol Assess; 2017 Apr; 21(18):1-100. PubMed ID: 28412995
[TBL] [Abstract][Full Text] [Related]
37. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
38. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study.
Teare MD; Dimairo M; Shephard N; Hayman A; Whitehead A; Walters SJ
Trials; 2014 Jul; 15():264. PubMed ID: 24993581
[TBL] [Abstract][Full Text] [Related]
39. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
Fay MP; Halloran ME; Follmann DA
Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
